Yaokai Chen to Middle Aged
This is a "connection" page, showing publications Yaokai Chen has written about Middle Aged.
Connection Strength
0.043
-
Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol. Chin Med J (Engl). 2020 May 05; 133(9):1132-1134.
Score: 0.014
-
SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants. Microbiol Spectr. 2021 09 03; 9(1):e0026121.
Score: 0.004
-
Patterns of IgG and IgM antibody response in COVID-19 patients. Emerg Microbes Infect. 2020 Dec; 9(1):1269-1274.
Score: 0.004
-
Effect of SARS-CoV-2 coinfection was not apparent on the dynamics of chronic hepatitis B infection. Virology. 2021 01 15; 553:131-134.
Score: 0.004
-
The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multi-center case series. Signal Transduct Target Ther. 2020 10 06; 5(1):219.
Score: 0.004
-
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19. Signal Transduct Target Ther. 2020 09 02; 5(1):180.
Score: 0.004
-
Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2. Clin Microbiol Infect. 2020 Nov; 26(11):1556.e1-1556.e6.
Score: 0.004
-
A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019. J Infect Dis. 2020 06 29; 222(2):189-193.
Score: 0.004
-
Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020 06; 26(6):845-848.
Score: 0.004